Ctt Pharmaceutical Holdings Stock Analysis
| CTTH Stock | USD 0.1 0.01 7.95% |
CTT Pharmaceutical holds a debt-to-equity ratio of 0.118. With a high degree of financial leverage come high-interest payments, which usually reduce CTT Pharmaceutical's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
CTT Pharmaceutical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. CTT Pharmaceutical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps CTT Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect CTT Pharmaceutical's stakeholders.
For many companies, including CTT Pharmaceutical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for CTT Pharmaceutical Holdings, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, CTT Pharmaceutical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that CTT Pharmaceutical's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which CTT Pharmaceutical is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of CTT Pharmaceutical to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, CTT Pharmaceutical is said to be less leveraged. If creditors hold a majority of CTT Pharmaceutical's assets, the Company is said to be highly leveraged.
CTT Pharmaceutical Holdings is overvalued with Real Value of 0.0718 and Hype Value of 0.1. The main objective of CTT Pharmaceutical pink sheet analysis is to determine its intrinsic value, which is an estimate of what CTT Pharmaceutical Holdings is worth, separate from its market price. There are two main types of CTT Pharmaceutical's stock analysis: fundamental analysis and technical analysis.
The CTT Pharmaceutical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CTT Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
CTT |
CTT Pink Sheet Analysis Notes
The company recorded a loss per share of 0.08. CTT Pharmaceutical had not issued any dividends in recent years. The entity had 1:10 split on the 28th of August 2015. CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.The quote for CTT Pharmaceutical Holdings is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on CTT Pharmaceutical Holdings please contact the company at 613-241-9959 or go to https://www.cttpharmaceuticals.com.CTT Pharmaceutical Investment Alerts
| CTT Pharmaceutical is way too risky over 90 days horizon | |
| CTT Pharmaceutical has some characteristics of a very speculative penny stock | |
| CTT Pharmaceutical appears to be risky and price may revert if volatility continues | |
| CTT Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 40 K. Net Loss for the year was (1.38 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CTT Pharmaceutical Holdings currently holds about 32.12 K in cash with (145.16 K) of positive cash flow from operations. |
CTT Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CTT Pharmaceutical's market, we take the total number of its shares issued and multiply it by CTT Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 13th of February 2026, CTT Pharmaceutical shows the mean deviation of 8.04, and Risk Adjusted Performance of 0.0981. CTT Pharmaceutical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.CTT Pharmaceutical Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in CTT Pharmaceutical price series with the more recent values given greater weights.
CTT Pharmaceutical Outstanding Bonds
CTT Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CTT Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CTT bonds can be classified according to their maturity, which is the date when CTT Pharmaceutical Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| US12657NAA81 Corp BondUS12657NAA81 | View | |
| US12653CAJ71 Corp BondUS12653CAJ71 | View | |
| CNX 7375 15 JAN 31 Corp BondUS12653CAK45 | View | |
| US12654AAA97 Corp BondUS12654AAA97 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
CTT Pharmaceutical Predictive Daily Indicators
CTT Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CTT Pharmaceutical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 5341.47 | |||
| Daily Balance Of Power | 1.4 | |||
| Rate Of Daily Change | 1.08 | |||
| Day Median Price | 0.0925 | |||
| Day Typical Price | 0.0933 | |||
| Price Action Indicator | 0.006 | |||
| Period Momentum Indicator | 0.007 |
CTT Pharmaceutical Forecast Models
CTT Pharmaceutical's time-series forecasting models are one of many CTT Pharmaceutical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CTT Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.CTT Pharmaceutical Debt to Cash Allocation
CTT Pharmaceutical Holdings currently holds 87.62 K in liabilities with Debt to Equity (D/E) ratio of 0.12, which may suggest the company is not taking enough advantage from borrowing. CTT Pharmaceutical has a current ratio of 4.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist CTT Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, CTT Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CTT Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CTT to invest in growth at high rates of return. When we think about CTT Pharmaceutical's use of debt, we should always consider it together with cash and equity.CTT Pharmaceutical Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the CTT Pharmaceutical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of CTT Pharmaceutical, which in turn will lower the firm's financial flexibility.CTT Pharmaceutical Corporate Bonds Issued
Most CTT bonds can be classified according to their maturity, which is the date when CTT Pharmaceutical Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About CTT Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how CTT Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CTT shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as CTT Pharmaceutical. By using and applying CTT Pink Sheet analysis, traders can create a robust methodology for identifying CTT entry and exit points for their positions.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding CTT Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Complementary Tools for CTT Pink Sheet analysis
When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |